MFIM
MIRM icon

Mesirow Financial Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Mesirow Financial Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,795
Closed -$514K – 86
2021
Q3 		$514K Buy
+25,795
New +$420K 1.51% 22

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mesirow Financial Investment Management's MIRM Position: Q4 2021 in Review

Mesirow Financial Investment Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2021, closing a stake of 25,795 shares — an estimated $514K sold.

Mesirow Financial Investment Management first reported a position in MIRM in Q3 2021 and held it in 1 quarter. The position peaked at $514K in Q3 2021. 86 funds tracked by Wall St. Rank hold MIRM as of Q4 2021.

  • Mesirow Financial Investment Management reported no remaining Mirum Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 25,795 Mirum Pharmaceuticals shares in Q4 2021, an estimated $514K.
  • Mesirow Financial Investment Management first reported a position in Mirum Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Mesirow Financial Investment Management's Mirum Pharmaceuticals position peaked at $514K in Q3 2021.
  • 86 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2021, filed 14 Jan 2022.